Viral persistence in vivo through selection of neutralizing antibody-escape variants
AUTOR(ES)
Ciurea, Adrian
FONTE
The National Academy of Sciences
RESUMO
Despite initial virus control by CD8+ cytotoxic T lymphocytes (CTLs), noncytopathic or variably cytopathic viruses (e.g., hepatitis B and C viruses, HIV) are able to establish persistent infections. The role of neutralizing antibodies (nAbs) in controlling disease progression is unclear. Therefore, the phenomenon of viral evasion from the nAb response and its implications for virus persistence remain controversial. Here we demonstrate nAb-mediated viral clearance in CTL-deficient mice infected with the prototypic noncytopathic lymphocytic choriomeningitis virus (strain WE). During prolonged CTL absence, neutralization-resistant virus mutants were selected in individual mice within 70–90 days. In naïve animals infected with these virus variants only low nAb responses were induced, resulting in an increased tendency of virus to persist.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=16001Documentos Relacionados
- Additive Effect of Neutralizing Antibody and Antiviral Drug Treatment in Preventing Virus Escape and Persistence
- Control of Central Nervous System Viral Persistence by Neutralizing Antibody
- Viral spread in the presence of neutralizing antibody: mechanisms of persistence in foamy virus infection.
- Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection
- Identification of antigenically important domains in the glycoproteins of Sindbis virus by analysis of antibody escape variants.